Cybin Inc

Pharmaceutical Stocks Healthcare Stocks

$13.90

+0.24 (+1.76%)

As of Sep 22, 6:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target -30.1% upside

Low Target $6.32

Average Target $9.72

High Target $10.76

Current Price $13.90

Current
$13.90

Target
$9.72

$6.32 $9.72 avg $10.76

Scenario Analysis

Bear Case

$6.32

-54.5%

Low target

Base Case

$9.72

-30.1%

Avg target

Bull Case

$10.76

+-22.6%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$19.86

-30.0% from high

52-Week Low

$5.30

+162.3% from low

Target vs 52W High

$9.72

-51.1% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.8%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.1%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.0%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.6%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+178.7%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+187.5%